Search Results
38 Results for 'Drug production & design'
PAGE 1 OF 2
Technology
Photochemical Preparation of Fluorinated Aryl Ethers for Agrochemicals and Pharmaceuticals
The element fluorine has acquired an ever-increasing prevalence in synthetic drugs and agrochemicals due to its positive impact on the metabolism, chemical stability, and modulating lipophilicity of a...
Learn More
Learn More
Ian Mackenzie, Mark Levenstein | T230006US02
Technology
Thioamide Analogues Of Peptide Antigens
UW-Madison researchers have developed a method of stabilizing short antigenic peptides that act as vaccines against infectious disease or cancer. Peptides that bind major histocompatibility complex I ...
Learn More
Learn More
Samuel Gellman, Rylie Morris, Ruslan Gibadullin, Jiani Niu | P230415US02
Technology
Cyclic Peptide-Based Lysosome Targeting Degraders
UW-Madison researchers have developed a protein degrader that shuttles targeted extracellular protein into the lysosome using a cyclic peptide that binds to a cellular receptor attached to a binding m...
Learn More
Learn More
Weiping Tang, Yaxian Zhou, Yuan Zhao | P220339WO01
Technology
Activating Appendages To Induce Polypharmacology In Peptide Hormone Analogues, Including Dual GLP-1R / GIP Agonism
UW-Madison researchers have developed a synthetic peptide through a single amino acid substitution and chemical conjugation of an aromatic molecule at the site of mutation that turns a peptide that bi...
Learn More
Learn More
Samuel Gellman, Kyle Brown, Rylie Morris | P230413US02
Technology
Clostridium Botulinum Strain 62a
UW-Madison researchers have a Clostridium botulinum strain 62A that is a sporulating C. botulinum strain producing high levels of BoNT/A1. A bacterial stock was prepared from a single colony and seque...
Learn More
Learn More
Sabine Pellett, William Tepp, Eric Johnson | P240033US01
Technology
Synthesis Of Novel Cereblon E3 Ligase Ligands, Compounds Formed Thereby, and Pharmaceutical Compositions Containing Them
UW-Madison researchers developed a novel class of molecules that bind cereblon (CRBN), a ubiquitin ligase. These molecules may be used in the development of PROTAC therapeutics. The researchers starte...
Learn More
Learn More
Weiping Tang, Haibo Xie, Yunxiang Wu, Junzhuo Liao, Chunrong Li, Ira Tandon, Hua Tang | P230003US02
Technology
Developing Specific Rheumatoid Factors as Diagnostic and Therapeutic Tools
Rheumatoid factors (RFs) are antibodies that commonly develop in patients with rheumatoid arthritis (RA), an incurable autoimmune disease that affects ~1% of the population. RFs bind to IgG and other ...
Learn More
Learn More
Miriam Shelef | P220084US02
Technology
Method Of Manufacturing Micelles For Drug Delivery
UW Madison researchers have developed a novel way to manufacture large amount of micellular paclitaxel. Rather than using organic solvents to get the paclitaxel solubilized and loaded into micelles, t...
Learn More
Learn More
Glen Kwon, Morteza Rasoulianboroujeni, Rae Hyung Kang | P220070US02
Technology
UW-Madison researchers have developed a highly efficient biocatalytic route for production of diverse γ-hydroxy amino acids starting from L-aspartate and readily available aldehydes. The method lever...
Learn More
Learn More
Andrew Buller, Jonathan Ellis, Prasanth Kumar | P190336US02
Technology
Neoglycorandomization And Digitoxin Analogs
The present invention provides methods of producing libraries of compounds with enhanced desirable properties and diminished side effects as well as the compounds produced by the methods. In preferred...
Learn More
Learn More
Joseph Langenhan | P08057US
Technology
Enhanced Neoglycosides Through Neoglycosylation And Methods Of Use Thereof
Using neoglycosylation, the impact of differential glycosylation upon the divergent anticancer and anti-HIV properties of the triterpenoid betulinic acid (BA) was examined. Each member from a library ...
Learn More
Learn More
Jon Thorson, Randal Goff | P07498US02
Technology
Compositions,m Ethods And Devices For Preparing Less Painful Botulinum Toxin Formulations
Devices, methods and kits are disclosed for preparing and administering less-painful formulations of Botulinum toxin. The devices, methods and kits of the present invention are comprised of or use an ...
Learn More
Learn More
Gary Borodic, Martin Acquadro | P05406US
Technology
Method Of Preparing Botulinum Neurotoxin Type A Light Chain
The present invention provides a preparation of botulinum toxin light chain type A or E, wherein the preparation is both catalytically active and soluble. Preferably, the preparation consists essentia...
Learn More
Learn More
Eric Johnson, Marite Bradshaw, Joseph Barbieri, Michael Baldwin | P04467US
Technology
Synthesis Of Small Molecule Histone Deacetylase 6 Degraders, Compounds Formed Thereby, And Pharmaceutical Compositions Containing Them
Histone deacetylase (“HDAC”)-selective inhibitors covalently bonded to a linker covalently bonded to an E3 ubiquitin ligase ligand, and salts thereof; pharmaceutical compositions containing them; ...
Learn More
Learn More
Weiping Tang, Ka Yang, Hao Wu, Zhongrui Zhang | P180321US05
Technology
Photochemical Methods Of Making Cyclobutane Boronates And Related Compounds
The present technology relates generally cyclobutane boronates, including methods of preparation by exposing a mixture of a compound of Formula I in a solvent [Image Omitted] and a catalytic amount o...
Learn More
Learn More
Tehshik Yoon, Spencer Scholz, Rowan Littlefield, Niecia Flikweert | P170290US02
Technology
Using Liquid Crystal To Detect Endotoxin In The Presence Of One Or More Potential Masking Agents
Devices and methods for using changes in the configuration of micrometer sized dispersed liquid crystal domains to detect or quantify analytes in a test sample, including endotoxin lipopolysaccharide ...
Learn More
Learn More
Nicholas Abbott, Abhijit Dan | P160072US02
Technology
Engineered Prephenate Dehydrogenases And Arogenate Dehydrogenases And Methods Of Using The Same
The invention generally relates to engineered prephenate dehydrogenases and arogenate dehydrogenases and methods of using the same. More specifically, the invention relates in part to compositions inc...
Learn More
Learn More
Hiroshi Maeda, Craig Schenck | P170121US02
Technology
Arogenate Dehydrogenase Polynucleotides, Polypeptides And Methods Of Using The Same
The invention generally relates to arogenate dehydrogenase polynucleotides and methods of using the same. More specifically, the invention relates in part to compositions including arogenate dehydroge...
Learn More
Learn More
Hiroshi Maeda, Samuel Lopez Nieves, Marcos Vinicius Viana de Oliveira | P170120US02
Technology
Coated Egg Yolk Cores, Methods Of Making And Methods Of Use Thereof
A method of making coated avian egg yolk cores includes providing dried avian egg yolk cores having a diameter of 100 to 1500 micrometers, applying avian egg albumen to the dried avian egg yolk cores ...
Learn More
Learn More
Mark Cook, Jordan Sand | P170345US01
Technology
Expansion And Maintenance Of Adult Primary Human Hepatocytes In Culture
Methods for derivation, culture, and maturation of small hepatic progenitor cells are described.
Learn More
Learn More
James Thomson, Srikumar Sengupta | P180325US03
Technology
Synthesis Of Small Molecule Histone Deacetylase 6 Degraders, Compounds Formed Thereby, And Pharmaceutical Compositions Containing Them
Histone deacetylase (“HDAC”)-selective inhibitors covalently bonded to a linker covalently bonded to an E3 ubiquitin ligase ligand, and salts thereof; pharmaceutical compositions containing them; ...
Learn More
Learn More
Weiping Tang, Ka Yang, Hao Wu | P180321US03
Technology
Research Tool for Protein Conformation Analysis
The three-dimensional structure of proteins can be studied in solution using various methods of covalent and noncovalent labeling in which the readout is accomplished by mass spectrometry (MS). These ...
Learn More
Learn More
Michael Sussman, J. Leon Shohet, Faraz Choudhury, Joshua Blatz, Benjamin Minkoff, Daniel Benjamin | P160180US02
Technology
Yeast-Based Intein Platform for Drug Production
The therapeutic and biochemical properties of proteins including antibodies can be enhanced by custom chemical functionalization that enables modifications, such as small molecule drug conjugation, PE...
Learn More
Learn More
Eric Shusta, Cathryn Marshall | P150056US02
Technology
Small Molecule Catalysts of Oxidative Protein Folding
Approximately 20 percent of human proteins – including many of high pharmaceutical relevance – are believed to contain disulfide bonds critical for proper structure and function. However, producin...
Learn More
Learn More
Ronald Raines, John Lukesh | P150010US02
Technology
Enhanced Endotoxin Detection: New Advantages in Liquid Crystal Assays for Gram-Negative Pathogens
Gram-negative bacterial infections are an ongoing challenge to health care providers worldwide. Detection, treatment and control of such pathogens have gained increasing importance in the context of a...
Learn More
Learn More
Nicholas Abbott, Abhijit Dan | P160072WO01